Aurobindo Pharma Ltd 2024 SR
The report for Aurobindo Pharma Limited for the fiscal year 2023-24 highlights the company's progress toward its 2025 sustainability goals. Key achievements include a 16% reduction in carbon footprint, surpassing the 12.5% target, and reaching a 14% renewable energy share. The company also achieved 36% water conservation/restoration and 100% reuse/recycle of non-hazardous waste. Socially, gender diversity reached 12.54% of the workforce. The report, prepared on a consolidated basis, received reasonable assurance from Sharp & Tannan Associates for its BRSR Core indicators.
Company: Aurobindo Pharma Ltd
Sector: Health Care
Country: India
Year: 2024
Type: SR
Pages: 41
Aurobindo Pharma Ltd
Business Responsibility And Sustainability Report
The report for Aurobindo Pharma Limited for the fiscal year 2023-24 highlights the company's progress toward its 2025 sustainability goals. Key achievements include a 16% reduction in carbon footprint, surpassing the 12.5% target, and reaching a 14% renewable energy share. The company also achieved 36% water conservation/restoration and 100% reuse/recycle of non-hazardous waste. Socially, gender diversity reached 12.54% of the workforce. The report, prepared on a consolidated basis, received reasonable assurance from Sharp & Tannan Associates for its BRSR Core indicators.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2024
Published
Jul 18, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees